

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 5.40915448 |
| 2 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.18828292 |
| 3 | myofibril assembly (GO:0030239) | 4.61295479 |
| 4 | sarcomere organization (GO:0045214) | 4.60415294 |
| 5 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.09941759 |
| 6 | glucocorticoid biosynthetic process (GO:0006704) | 4.08089699 |
| 7 | regulation of actin filament-based movement (GO:1903115) | 3.81785269 |
| 8 | actin-myosin filament sliding (GO:0033275) | 3.78324789 |
| 9 | muscle filament sliding (GO:0030049) | 3.78324789 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.75832135 |
| 11 | heart trabecula formation (GO:0060347) | 3.73924695 |
| 12 | cardiac muscle contraction (GO:0060048) | 3.68852487 |
| 13 | surfactant homeostasis (GO:0043129) | 3.67465318 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64393293 |
| 15 | blood vessel maturation (GO:0001955) | 3.62738040 |
| 16 | lymph vessel development (GO:0001945) | 3.59586585 |
| 17 | cardiac muscle hypertrophy (GO:0003300) | 3.59263563 |
| 18 | venous blood vessel morphogenesis (GO:0048845) | 3.55162458 |
| 19 | striated muscle hypertrophy (GO:0014897) | 3.54195719 |
| 20 | regulation of sarcomere organization (GO:0060297) | 3.53411487 |
| 21 | exogenous drug catabolic process (GO:0042738) | 3.51121707 |
| 22 | chemical homeostasis within a tissue (GO:0048875) | 3.49240662 |
| 23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.45874531 |
| 24 | drug catabolic process (GO:0042737) | 3.44730259 |
| 25 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.42985507 |
| 26 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.42555417 |
| 27 | plasma membrane repair (GO:0001778) | 3.36906654 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.33981025 |
| 29 | actomyosin structure organization (GO:0031032) | 3.33371160 |
| 30 | negative regulation of complement activation (GO:0045916) | 3.31742412 |
| 31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.29027270 |
| 32 | reverse cholesterol transport (GO:0043691) | 3.27498127 |
| 33 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.26528970 |
| 34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.25518826 |
| 35 | regulation of relaxation of muscle (GO:1901077) | 3.23178646 |
| 36 | regulation of endothelial cell differentiation (GO:0045601) | 3.21391912 |
| 37 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.20721418 |
| 38 | actin-mediated cell contraction (GO:0070252) | 3.20327181 |
| 39 | muscle hypertrophy (GO:0014896) | 3.19586164 |
| 40 | atrioventricular valve morphogenesis (GO:0003181) | 3.16111455 |
| 41 | negative regulation of heart growth (GO:0061117) | 3.15896627 |
| 42 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.15896627 |
| 43 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.15153348 |
| 44 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.14813001 |
| 45 | dendritic spine morphogenesis (GO:0060997) | 3.14548082 |
| 46 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.11152037 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 3.09407141 |
| 48 | negative regulation of protein activation cascade (GO:2000258) | 3.09314382 |
| 49 | cardiac muscle cell development (GO:0055013) | 3.09311169 |
| 50 | epoxygenase P450 pathway (GO:0019373) | 3.09041957 |
| 51 | lymphangiogenesis (GO:0001946) | 3.08627213 |
| 52 | glucocorticoid metabolic process (GO:0008211) | 3.08044065 |
| 53 | oxygen transport (GO:0015671) | 3.08033349 |
| 54 | muscle tissue morphogenesis (GO:0060415) | 3.05735633 |
| 55 | regulation of skeletal muscle contraction (GO:0014819) | 3.03912898 |
| 56 | synaptic vesicle maturation (GO:0016188) | 3.00844418 |
| 57 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.99659047 |
| 58 | complement activation, classical pathway (GO:0006958) | 2.98109505 |
| 59 | regulation of cell communication by electrical coupling (GO:0010649) | 2.97679134 |
| 60 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.96570709 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96081179 |
| 62 | oxidative demethylation (GO:0070989) | 2.95032370 |
| 63 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.94097929 |
| 64 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.94008143 |
| 65 | striated muscle contraction (GO:0006941) | 2.92803467 |
| 66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.92653673 |
| 67 | endocardial cushion morphogenesis (GO:0003203) | 2.91407193 |
| 68 | glomerular basement membrane development (GO:0032836) | 2.90727623 |
| 69 | trabecula formation (GO:0060343) | 2.89845016 |
| 70 | cardiac cell development (GO:0055006) | 2.88757908 |
| 71 | auditory receptor cell stereocilium organization (GO:0060088) | 2.88075782 |
| 72 | adult heart development (GO:0007512) | 2.85251709 |
| 73 | high-density lipoprotein particle remodeling (GO:0034375) | 2.84445706 |
| 74 | regulation of cardioblast differentiation (GO:0051890) | 2.83826738 |
| 75 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.83468557 |
| 76 | regulation of synapse maturation (GO:0090128) | 2.81248616 |
| 77 | regulation of the force of heart contraction (GO:0002026) | 2.80799098 |
| 78 | regulation of apoptotic cell clearance (GO:2000425) | 2.79342542 |
| 79 | cGMP biosynthetic process (GO:0006182) | 2.78946240 |
| 80 | regulation of striated muscle contraction (GO:0006942) | 2.77383899 |
| 81 | gamma-aminobutyric acid transport (GO:0015812) | 2.77090217 |
| 82 | tricarboxylic acid cycle (GO:0006099) | 2.76641823 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 2.76111912 |
| 84 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.76078662 |
| 85 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.74504163 |
| 86 | regulation of female receptivity (GO:0045924) | 2.73376438 |
| 87 | complement activation (GO:0006956) | 2.73303764 |
| 88 | ethanol oxidation (GO:0006069) | 2.72511961 |
| 89 | cardiac muscle adaptation (GO:0014887) | 2.72483336 |
| 90 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.72483336 |
| 91 | muscle hypertrophy in response to stress (GO:0003299) | 2.72483336 |
| 92 | cell communication involved in cardiac conduction (GO:0086065) | 2.72375333 |
| 93 | L-phenylalanine catabolic process (GO:0006559) | 2.71720823 |
| 94 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.71720823 |
| 95 | omega-hydroxylase P450 pathway (GO:0097267) | 2.70875039 |
| 96 | ketone body metabolic process (GO:1902224) | 2.70811668 |
| 97 | auditory behavior (GO:0031223) | 2.70580631 |
| 98 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.70403726 |
| 99 | toxin metabolic process (GO:0009404) | 2.68415816 |
| 100 | positive regulation of vasculogenesis (GO:2001214) | 2.67755410 |
| 101 | protein activation cascade (GO:0072376) | 2.66784538 |
| 102 | glyoxylate metabolic process (GO:0046487) | 2.66205632 |
| 103 | opsonization (GO:0008228) | 2.63893829 |
| 104 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.63290689 |
| 105 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.62897775 |
| 106 | glomerular filtration (GO:0003094) | 2.61010150 |
| 107 | aromatic amino acid family catabolic process (GO:0009074) | 2.60057792 |
| 108 | regulation of complement activation (GO:0030449) | 2.58836974 |
| 109 | macroautophagy (GO:0016236) | 2.57976578 |
| 110 | lysine metabolic process (GO:0006553) | 2.57722921 |
| 111 | lysine catabolic process (GO:0006554) | 2.57722921 |
| 112 | actin filament-based movement (GO:0030048) | 2.57059047 |
| 113 | endocardial cushion development (GO:0003197) | 2.56269983 |
| 114 | regulation of protein activation cascade (GO:2000257) | 2.55264145 |
| 115 | neuronal action potential propagation (GO:0019227) | 2.54409213 |
| 116 | regulation of beta-amyloid formation (GO:1902003) | 2.54249524 |
| 117 | axon ensheathment in central nervous system (GO:0032291) | 2.53687547 |
| 118 | central nervous system myelination (GO:0022010) | 2.53687547 |
| 119 | glutamate secretion (GO:0014047) | 2.53344271 |
| 120 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.52584550 |
| 121 | regulation of membrane repolarization (GO:0060306) | 2.52251837 |
| 122 | plasma lipoprotein particle remodeling (GO:0034369) | 2.52230436 |
| 123 | protein-lipid complex remodeling (GO:0034368) | 2.52230436 |
| 124 | macromolecular complex remodeling (GO:0034367) | 2.52230436 |
| 125 | cardiac conduction (GO:0061337) | 2.51470528 |
| 126 | detection of calcium ion (GO:0005513) | 2.51370837 |
| 127 | regulation of vasculogenesis (GO:2001212) | 2.50908357 |
| 128 | indole-containing compound catabolic process (GO:0042436) | 2.49690653 |
| 129 | indolalkylamine catabolic process (GO:0046218) | 2.49690653 |
| 130 | tryptophan catabolic process (GO:0006569) | 2.49690653 |
| 131 | proline transport (GO:0015824) | 2.49349850 |
| 132 | membrane depolarization during action potential (GO:0086010) | 2.48858962 |
| 133 | regulation of cardiac muscle contraction (GO:0055117) | 2.48293285 |
| 134 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.47435448 |
| 135 | vocalization behavior (GO:0071625) | 2.47327041 |
| 136 | cell communication by electrical coupling (GO:0010644) | 2.47044416 |
| 137 | positive regulation of fatty acid oxidation (GO:0046321) | 2.46847406 |
| 138 | mesenchyme morphogenesis (GO:0072132) | 2.46550638 |
| 139 | cardiac chamber formation (GO:0003207) | 2.46425080 |
| 140 | negative regulation of protein localization to cell surface (GO:2000009) | 2.46060012 |
| 141 | homocysteine metabolic process (GO:0050667) | 2.45902169 |
| 142 | outflow tract septum morphogenesis (GO:0003148) | 2.44370517 |
| 143 | gas transport (GO:0015669) | 2.44040320 |
| 144 | neurotransmitter secretion (GO:0007269) | 2.43942760 |
| 145 | cellular sodium ion homeostasis (GO:0006883) | 2.42711261 |
| 146 | alanine transport (GO:0032328) | 2.42372618 |
| 147 | nitric oxide mediated signal transduction (GO:0007263) | 2.41247940 |
| 148 | fatty acid transmembrane transport (GO:1902001) | 2.41132901 |
| 149 | cardiac muscle cell action potential (GO:0086001) | 2.40851500 |
| 150 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.40206558 |
| 151 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.38105220 |
| 152 | glycerophospholipid catabolic process (GO:0046475) | 2.37927628 |
| 153 | positive regulation of synapse maturation (GO:0090129) | 2.37844134 |
| 154 | primary amino compound metabolic process (GO:1901160) | 2.37605168 |
| 155 | carnitine shuttle (GO:0006853) | 2.36021773 |
| 156 | renal filtration (GO:0097205) | 2.35788427 |
| 157 | phenylpropanoid metabolic process (GO:0009698) | 2.35719020 |
| 158 | complement activation, alternative pathway (GO:0006957) | 2.35413221 |
| 159 | nephron tubule morphogenesis (GO:0072078) | 2.34063388 |
| 160 | nephron epithelium morphogenesis (GO:0072088) | 2.34063388 |
| 161 | regulation of heart rate (GO:0002027) | 2.34062242 |
| 162 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.34048068 |
| 163 | cGMP metabolic process (GO:0046068) | 2.33636832 |
| 164 | 2-oxoglutarate metabolic process (GO:0006103) | 2.33366631 |
| 165 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.33292553 |
| 166 | female mating behavior (GO:0060180) | 2.32533784 |
| 167 | response to misfolded protein (GO:0051788) | 2.32135596 |
| 168 | regulation of glucokinase activity (GO:0033131) | 2.31772940 |
| 169 | regulation of hexokinase activity (GO:1903299) | 2.31772940 |
| 170 | potassium ion import (GO:0010107) | 2.30346613 |
| 171 | S-adenosylmethionine metabolic process (GO:0046500) | 2.29581146 |
| 172 | response to dietary excess (GO:0002021) | 2.28584776 |
| 173 | postsynaptic membrane organization (GO:0001941) | 2.27864564 |
| 174 | potassium ion export (GO:0071435) | 2.27155017 |
| 175 | atrial cardiac muscle cell action potential (GO:0086014) | 2.27105718 |
| 176 | benzene-containing compound metabolic process (GO:0042537) | 2.26127962 |
| 177 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.26103668 |
| 178 | triglyceride homeostasis (GO:0070328) | 2.26097925 |
| 179 | acylglycerol homeostasis (GO:0055090) | 2.26097925 |
| 180 | renal tubule morphogenesis (GO:0061333) | 2.25378555 |
| 181 | blood coagulation, intrinsic pathway (GO:0007597) | 2.24879282 |
| 182 | synaptic vesicle exocytosis (GO:0016079) | 2.24628262 |
| 183 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.22599543 |
| 184 | sodium-independent organic anion transport (GO:0043252) | 2.22558483 |
| 185 | neuronal ion channel clustering (GO:0045161) | 2.22128063 |
| 186 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.21669390 |
| 187 | regulation of fibrinolysis (GO:0051917) | 2.21519994 |
| 188 | potassium ion transmembrane transport (GO:0071805) | 2.20838181 |
| 189 | cellular potassium ion transport (GO:0071804) | 2.20838181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.19114873 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.88387542 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.70501757 |
| 4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.66891384 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.51061625 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.27382539 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.21916942 |
| 8 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20447991 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19533759 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.17048097 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16497454 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12551920 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12551920 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.09818857 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08131011 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02833299 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00928347 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97072845 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.91114921 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90694488 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88726103 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.85494911 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85179927 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81865336 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.77391518 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73241387 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.67777197 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66150106 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65015602 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64819486 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63999950 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.63762737 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60962357 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.56128223 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55960222 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54951510 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54415037 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53000551 |
| 39 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.50487361 |
| 40 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.50487361 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50422781 |
| 42 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50209827 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48461471 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48146223 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47556431 |
| 46 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42818163 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42388132 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41816059 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39653198 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39377339 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38965915 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38909928 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31903446 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31347003 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29693679 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28686235 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23034602 |
| 58 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22133042 |
| 59 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21613795 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20230327 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18181388 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18181388 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17844568 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.17187626 |
| 65 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16953103 |
| 66 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15963500 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15402488 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14378583 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14348428 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14196397 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13939867 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10896003 |
| 73 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10869739 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10571749 |
| 75 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09868766 |
| 76 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09814049 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08782531 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08707737 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08664893 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06667036 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05755765 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05354491 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05244573 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04942279 |
| 85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.04560600 |
| 86 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.04416706 |
| 87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03606384 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02576692 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02258866 |
| 90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01226826 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01052322 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00397626 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00143019 |
| 94 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99158078 |
| 95 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98854233 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98299738 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98195484 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97324033 |
| 99 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97025210 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96782008 |
| 101 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96054885 |
| 102 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96054885 |
| 103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95840725 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95719007 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95619655 |
| 106 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95334901 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95287744 |
| 108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94527484 |
| 109 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94249373 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92028487 |
| 111 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91769155 |
| 112 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90645052 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90049385 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89797753 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89772729 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88355348 |
| 117 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87497825 |
| 118 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87421749 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86609725 |
| 120 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.86603677 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86309965 |
| 122 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.86188767 |
| 123 | AR_19668381_ChIP-Seq_PC3_Human | 0.86109903 |
| 124 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.86030092 |
| 125 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85966093 |
| 126 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85687296 |
| 127 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85255618 |
| 128 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84086824 |
| 129 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83638972 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83619753 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82068425 |
| 132 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81458310 |
| 133 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81084065 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80808311 |
| 135 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80222476 |
| 136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80157223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.19687762 |
| 2 | MP0000751_myopathy | 4.44381720 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.20138860 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.77500222 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.73036647 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.49069757 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.03929320 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.00527683 |
| 9 | MP0005275_abnormal_skin_tensile | 2.99128859 |
| 10 | MP0004272_abnormal_basement_membrane | 2.91026637 |
| 11 | MP0005330_cardiomyopathy | 2.75069197 |
| 12 | MP0000749_muscle_degeneration | 2.71506863 |
| 13 | MP0001958_emphysema | 2.65244149 |
| 14 | MP0001879_abnormal_lymphatic_vessel | 2.38765960 |
| 15 | MP0003787_abnormal_imprinting | 2.33694543 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.29898593 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.28248063 |
| 18 | MP0004484_altered_response_of | 2.15090581 |
| 19 | MP0006138_congestive_heart_failure | 2.10964653 |
| 20 | MP0005385_cardiovascular_system_phenoty | 2.10959656 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 2.10959656 |
| 22 | MP0004270_analgesia | 2.08082875 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.05991036 |
| 24 | MP0003646_muscle_fatigue | 2.04546810 |
| 25 | MP0005620_abnormal_muscle_contractility | 1.96759612 |
| 26 | MP0005360_urolithiasis | 1.96347762 |
| 27 | MP0009745_abnormal_behavioral_response | 1.91389972 |
| 28 | MP0002272_abnormal_nervous_system | 1.90208596 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.89125867 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88505482 |
| 31 | MP0003828_pulmonary_edema | 1.86805857 |
| 32 | MP0004085_abnormal_heartbeat | 1.86472771 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.84125820 |
| 34 | MP0001486_abnormal_startle_reflex | 1.82845832 |
| 35 | MP0002064_seizures | 1.77033903 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.76599892 |
| 37 | MP0004510_myositis | 1.76464615 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.76045546 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.74226718 |
| 40 | MP0000750_abnormal_muscle_regeneration | 1.72787866 |
| 41 | MP0002127_abnormal_cardiovascular_syste | 1.69667462 |
| 42 | MP0002108_abnormal_muscle_morphology | 1.62515918 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.60033180 |
| 44 | MP0002139_abnormal_hepatobiliary_system | 1.52939050 |
| 45 | MP0002063_abnormal_learning/memory/cond | 1.51931187 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.50937689 |
| 47 | MP0003690_abnormal_glial_cell | 1.49736868 |
| 48 | MP0005085_abnormal_gallbladder_physiolo | 1.49294577 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.49038578 |
| 50 | MP0003137_abnormal_impulse_conducting | 1.48835139 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.48739786 |
| 52 | MP0005369_muscle_phenotype | 1.46662625 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.45942808 |
| 54 | MP0002106_abnormal_muscle_physiology | 1.43498476 |
| 55 | MP0001984_abnormal_olfaction | 1.42474623 |
| 56 | MP0003279_aneurysm | 1.41888696 |
| 57 | MP0004043_abnormal_pH_regulation | 1.39393183 |
| 58 | MP0001485_abnormal_pinna_reflex | 1.37854901 |
| 59 | MP0005379_endocrine/exocrine_gland_phen | 1.34807007 |
| 60 | MP0002822_catalepsy | 1.34654352 |
| 61 | MP0003283_abnormal_digestive_organ | 1.32446547 |
| 62 | MP0002269_muscular_atrophy | 1.30848357 |
| 63 | MP0004885_abnormal_endolymph | 1.30726948 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.30409210 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.28424449 |
| 66 | MP0002734_abnormal_mechanical_nocicepti | 1.26899351 |
| 67 | MP0001661_extended_life_span | 1.24804198 |
| 68 | MP0005595_abnormal_vascular_smooth | 1.24793872 |
| 69 | MP0004130_abnormal_muscle_cell | 1.24309624 |
| 70 | MP0005423_abnormal_somatic_nervous | 1.23898586 |
| 71 | MP0002733_abnormal_thermal_nociception | 1.22087220 |
| 72 | MP0000767_abnormal_smooth_muscle | 1.21327552 |
| 73 | MP0002557_abnormal_social/conspecific_i | 1.20974309 |
| 74 | MP0003045_fibrosis | 1.20639193 |
| 75 | MP0005365_abnormal_bile_salt | 1.19388041 |
| 76 | MP0005165_increased_susceptibility_to | 1.18937154 |
| 77 | MP0000747_muscle_weakness | 1.18138660 |
| 78 | MP0001970_abnormal_pain_threshold | 1.17568490 |
| 79 | MP0004145_abnormal_muscle_electrophysio | 1.16734068 |
| 80 | MP0003633_abnormal_nervous_system | 1.15774603 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.15668155 |
| 82 | MP0002254_reproductive_system_inflammat | 1.14455718 |
| 83 | MP0008004_abnormal_stomach_pH | 1.14075367 |
| 84 | MP0008872_abnormal_physiological_respon | 1.13663495 |
| 85 | MP0003329_amyloid_beta_deposits | 1.11562816 |
| 86 | MP0000639_abnormal_adrenal_gland | 1.10452859 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09697232 |
| 88 | MP0000759_abnormal_skeletal_muscle | 1.09046986 |
| 89 | MP0000230_abnormal_systemic_arterial | 1.07798656 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 1.07712910 |
| 91 | MP0003252_abnormal_bile_duct | 1.05975102 |
| 92 | MP0005386_behavior/neurological_phenoty | 1.03953199 |
| 93 | MP0004924_abnormal_behavior | 1.03953199 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 1.03048176 |
| 95 | MP0004233_abnormal_muscle_weight | 0.99707066 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.98340578 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.97796264 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.97140625 |
| 99 | MP0003122_maternal_imprinting | 0.96440027 |
| 100 | MP0005448_abnormal_energy_balance | 0.95806467 |
| 101 | MP0003724_increased_susceptibility_to | 0.95275169 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.95250135 |
| 103 | MP0005535_abnormal_body_temperature | 0.95052196 |
| 104 | MP0009840_abnormal_foam_cell | 0.94731419 |
| 105 | MP0002933_joint_inflammation | 0.93330980 |
| 106 | MP0002090_abnormal_vision | 0.91588042 |
| 107 | MP0002735_abnormal_chemical_nociception | 0.91173453 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.90886212 |
| 109 | MP0003950_abnormal_plasma_membrane | 0.90138364 |
| 110 | MP0003880_abnormal_central_pattern | 0.89068443 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.88618041 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.88388529 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 0.87601063 |
| 114 | MP0002128_abnormal_blood_circulation | 0.86706275 |
| 115 | MP0000343_altered_response_to | 0.86645784 |
| 116 | MP0003631_nervous_system_phenotype | 0.85531834 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.85377336 |
| 118 | MP0005332_abnormal_amino_acid | 0.83942537 |
| 119 | MP0002229_neurodegeneration | 0.82985369 |
| 120 | MP0005171_absent_coat_pigmentation | 0.81287149 |
| 121 | MP0002133_abnormal_respiratory_system | 0.80819287 |
| 122 | MP0005388_respiratory_system_phenotype | 0.80819287 |
| 123 | MP0003878_abnormal_ear_physiology | 0.80242251 |
| 124 | MP0005377_hearing/vestibular/ear_phenot | 0.80242251 |
| 125 | MP0008877_abnormal_DNA_methylation | 0.78705289 |
| 126 | MP0003191_abnormal_cellular_cholesterol | 0.78677796 |
| 127 | MP0000266_abnormal_heart_morphology | 0.78190057 |
| 128 | MP0002971_abnormal_brown_adipose | 0.77347172 |
| 129 | MP0002067_abnormal_sensory_capabilities | 0.77311879 |
| 130 | MP0003136_yellow_coat_color | 0.76582816 |
| 131 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73928470 |
| 132 | MP0005083_abnormal_biliary_tract | 0.72070985 |
| 133 | MP0000249_abnormal_blood_vessel | 0.69217314 |
| 134 | MP0005508_abnormal_skeleton_morphology | 0.67555233 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.65079882 |
| 136 | MP0001756_abnormal_urination | 0.62207307 |
| 137 | MP0003195_calcinosis | 0.61769873 |
| 138 | MP0004883_abnormal_blood_vessel | 0.61307780 |
| 139 | MP0008874_decreased_physiological_sensi | 0.59956148 |
| 140 | MP0002089_abnormal_postnatal_growth/wei | 0.59602122 |
| 141 | MP0001765_abnormal_ion_homeostasis | 0.56846151 |
| 142 | MP0005670_abnormal_white_adipose | 0.55964215 |
| 143 | MP0002060_abnormal_skin_morphology | 0.54654756 |
| 144 | MP0003635_abnormal_synaptic_transmissio | 0.54265302 |
| 145 | MP0002925_abnormal_cardiovascular_devel | 0.54246213 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.53831267 |
| 147 | MP0002118_abnormal_lipid_homeostasis | 0.53636044 |
| 148 | MP0003115_abnormal_respiratory_system | 0.52934153 |
| 149 | MP0003879_abnormal_hair_cell | 0.51976044 |
| 150 | MP0002234_abnormal_pharynx_morphology | 0.51925981 |
| 151 | MP0000534_abnormal_ureter_morphology | 0.51421341 |
| 152 | MP0002876_abnormal_thyroid_physiology | 0.51256260 |
| 153 | MP0004859_abnormal_synaptic_plasticity | 0.48614073 |
| 154 | MP0002909_abnormal_adrenal_gland | 0.48311645 |
| 155 | MP0009046_muscle_twitch | 0.47578477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.27271675 |
| 2 | Glomerulonephritis (HP:0000099) | 5.83732718 |
| 3 | Abnormality of complement system (HP:0005339) | 4.95095298 |
| 4 | Muscle fiber splitting (HP:0003555) | 4.64898926 |
| 5 | Ventricular tachycardia (HP:0004756) | 4.63621833 |
| 6 | Atrial fibrillation (HP:0005110) | 4.63038688 |
| 7 | Abnormality of the calf musculature (HP:0001430) | 4.57294418 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 4.47108775 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.40368641 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.32290374 |
| 11 | Primary atrial arrhythmia (HP:0001692) | 4.26835845 |
| 12 | Broad metatarsal (HP:0001783) | 4.15202886 |
| 13 | Supraventricular arrhythmia (HP:0005115) | 4.05096312 |
| 14 | Supraventricular tachycardia (HP:0004755) | 4.04567501 |
| 15 | Lipoatrophy (HP:0100578) | 4.00211970 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.99532882 |
| 17 | Exercise-induced myalgia (HP:0003738) | 3.94485568 |
| 18 | Polycythemia (HP:0001901) | 3.87381012 |
| 19 | Increased connective tissue (HP:0009025) | 3.71689448 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 3.67193285 |
| 21 | Syncope (HP:0001279) | 3.59785838 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 3.54293343 |
| 23 | Nephritis (HP:0000123) | 3.43114295 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 3.20413956 |
| 25 | Prolonged QT interval (HP:0001657) | 3.14553508 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 3.04777292 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.01815972 |
| 28 | Hematochezia (HP:0002573) | 2.99569926 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.98880654 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.97370113 |
| 31 | Subaortic stenosis (HP:0001682) | 2.97184794 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.97184794 |
| 33 | Ventricular arrhythmia (HP:0004308) | 2.92095416 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.91024214 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 2.80302611 |
| 36 | Focal seizures (HP:0007359) | 2.76927724 |
| 37 | Deep venous thrombosis (HP:0002625) | 2.75715585 |
| 38 | Protrusio acetabuli (HP:0003179) | 2.72819971 |
| 39 | Pulmonary artery stenosis (HP:0004415) | 2.69318310 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.68363166 |
| 41 | Hyperglycemia (HP:0003074) | 2.67526885 |
| 42 | Cerebral hemorrhage (HP:0001342) | 2.67098609 |
| 43 | Bundle branch block (HP:0011710) | 2.63002032 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 2.59925476 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.59195477 |
| 46 | Febrile seizures (HP:0002373) | 2.58807860 |
| 47 | Palpitations (HP:0001962) | 2.56258756 |
| 48 | Late onset (HP:0003584) | 2.55841488 |
| 49 | Hyperventilation (HP:0002883) | 2.54801370 |
| 50 | Xanthomatosis (HP:0000991) | 2.54331899 |
| 51 | Large for gestational age (HP:0001520) | 2.54177571 |
| 52 | Complement deficiency (HP:0004431) | 2.54099796 |
| 53 | Polydipsia (HP:0001959) | 2.50262313 |
| 54 | Abnormal drinking behavior (HP:0030082) | 2.50262313 |
| 55 | Increased circulating renin level (HP:0000848) | 2.49521447 |
| 56 | Myoglobinuria (HP:0002913) | 2.48933873 |
| 57 | Skin nodule (HP:0200036) | 2.47017862 |
| 58 | Enlarged penis (HP:0000040) | 2.47000422 |
| 59 | Myokymia (HP:0002411) | 2.41801161 |
| 60 | Joint hemorrhage (HP:0005261) | 2.38875695 |
| 61 | Limb-girdle muscle atrophy (HP:0003797) | 2.38649008 |
| 62 | Action tremor (HP:0002345) | 2.37521770 |
| 63 | Hypokalemia (HP:0002900) | 2.34609443 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.32253347 |
| 65 | Hemiparesis (HP:0001269) | 2.31543817 |
| 66 | Esophageal varix (HP:0002040) | 2.29561305 |
| 67 | Muscular dystrophy (HP:0003560) | 2.29525905 |
| 68 | Mesangial abnormality (HP:0001966) | 2.29412294 |
| 69 | Progressive cerebellar ataxia (HP:0002073) | 2.29120309 |
| 70 | Heart block (HP:0012722) | 2.28210184 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.27191167 |
| 72 | Ventricular fibrillation (HP:0001663) | 2.27151892 |
| 73 | Abnormality of potassium homeostasis (HP:0011042) | 2.26390617 |
| 74 | Central scotoma (HP:0000603) | 2.23736099 |
| 75 | Atrioventricular block (HP:0001678) | 2.23163281 |
| 76 | Visceral angiomatosis (HP:0100761) | 2.22864921 |
| 77 | Abnormal atrioventricular conduction (HP:0005150) | 2.22485132 |
| 78 | Ketoacidosis (HP:0001993) | 2.22480934 |
| 79 | Ankle contracture (HP:0006466) | 2.20915072 |
| 80 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.18895109 |
| 81 | Renal salt wasting (HP:0000127) | 2.18438917 |
| 82 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18147118 |
| 83 | Abnormal urine output (HP:0012590) | 2.17545452 |
| 84 | Hypoglycemic seizures (HP:0002173) | 2.13582658 |
| 85 | Tubular atrophy (HP:0000092) | 2.12654366 |
| 86 | Cavernous hemangioma (HP:0001048) | 2.12400590 |
| 87 | Nephronophthisis (HP:0000090) | 2.10998945 |
| 88 | Gaze-evoked nystagmus (HP:0000640) | 2.10594962 |
| 89 | Abnormal EKG (HP:0003115) | 2.10379836 |
| 90 | Postural instability (HP:0002172) | 2.10330399 |
| 91 | Type II lissencephaly (HP:0007260) | 2.09673787 |
| 92 | Myotonia (HP:0002486) | 2.08853648 |
| 93 | Fair hair (HP:0002286) | 2.08797961 |
| 94 | Epileptiform EEG discharges (HP:0011182) | 2.08784680 |
| 95 | Retinal atrophy (HP:0001105) | 2.07509483 |
| 96 | EEG with generalized epileptiform discharges (HP:0011198) | 2.06821555 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 2.06697219 |
| 98 | Polyuria (HP:0000103) | 2.05232270 |
| 99 | Hypoglycemic coma (HP:0001325) | 2.04964552 |
| 100 | Arthropathy (HP:0003040) | 2.04205237 |
| 101 | Facial shape deformation (HP:0011334) | 2.03872832 |
| 102 | Potter facies (HP:0002009) | 2.03872832 |
| 103 | Epileptic encephalopathy (HP:0200134) | 2.03751720 |
| 104 | Hypoplastic ischia (HP:0003175) | 2.03481717 |
| 105 | Spinal rigidity (HP:0003306) | 2.03406153 |
| 106 | Hypsarrhythmia (HP:0002521) | 2.01502703 |
| 107 | Hypokalemic alkalosis (HP:0001949) | 2.01411479 |
| 108 | Abnormality of renin-angiotensin system (HP:0000847) | 2.01349218 |
| 109 | Lymphangioma (HP:0100764) | 2.00235150 |
| 110 | Cerebral palsy (HP:0100021) | 1.98923544 |
| 111 | Dysdiadochokinesis (HP:0002075) | 1.98016161 |
| 112 | Conjunctival telangiectasia (HP:0000524) | 1.95854390 |
| 113 | Double outlet right ventricle (HP:0001719) | 1.95773598 |
| 114 | Congenital malformation of the right heart (HP:0011723) | 1.95773598 |
| 115 | Hyperaldosteronism (HP:0000859) | 1.95549508 |
| 116 | Abnormality of renal excretion (HP:0011036) | 1.93991189 |
| 117 | Abnormality of the renal cortex (HP:0011035) | 1.93502047 |
| 118 | Gout (HP:0001997) | 1.93335715 |
| 119 | Abnormality of the renal medulla (HP:0100957) | 1.92962214 |
| 120 | Hemangiomatosis (HP:0007461) | 1.92099761 |
| 121 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89668583 |
| 122 | Hip contracture (HP:0003273) | 1.89543934 |
| 123 | Congenital stationary night blindness (HP:0007642) | 1.89266600 |
| 124 | Ketosis (HP:0001946) | 1.88725751 |
| 125 | Distal lower limb amyotrophy (HP:0008944) | 1.88593357 |
| 126 | Ankle clonus (HP:0011448) | 1.86177499 |
| 127 | Metabolic alkalosis (HP:0200114) | 1.86014061 |
| 128 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.85873638 |
| 129 | Premature rupture of membranes (HP:0001788) | 1.85853172 |
| 130 | * Congestive heart failure (HP:0001635) | 1.85730469 |
| 131 | Bulbar palsy (HP:0001283) | 1.85274215 |
| 132 | Systemic lupus erythematosus (HP:0002725) | 1.85187871 |
| 133 | Obstructive sleep apnea (HP:0002870) | 1.84841334 |
| 134 | Intention tremor (HP:0002080) | 1.82977007 |
| 135 | Left ventricular hypertrophy (HP:0001712) | 1.82027090 |
| 136 | Generalized muscle weakness (HP:0003324) | 1.81717718 |
| 137 | Hyperkalemia (HP:0002153) | 1.81483754 |
| 138 | Tachypnea (HP:0002789) | 1.81097161 |
| 139 | Difficulty running (HP:0009046) | 1.81037487 |
| 140 | Spontaneous abortion (HP:0005268) | 1.80183064 |
| 141 | Hypomagnesemia (HP:0002917) | 1.80026456 |
| 142 | Difficulty climbing stairs (HP:0003551) | 1.79785997 |
| 143 | Abnormality of the ischium (HP:0003174) | 1.79493581 |
| 144 | Sleep apnea (HP:0010535) | 1.79148560 |
| 145 | Sudden cardiac death (HP:0001645) | 1.78637775 |
| 146 | Generalized hypopigmentation of hair (HP:0011358) | 1.78633416 |
| 147 | * Mitral stenosis (HP:0001718) | 1.77965849 |
| 148 | Palmoplantar keratoderma (HP:0000982) | 1.76898301 |
| 149 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76608543 |
| 150 | Abnormal eating behavior (HP:0100738) | 1.76288957 |
| 151 | Hypoplastic left heart (HP:0004383) | 1.76061228 |
| 152 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.75569325 |
| 153 | Testicular atrophy (HP:0000029) | 1.75191721 |
| 154 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74459688 |
| 155 | Torticollis (HP:0000473) | 1.73148991 |
| 156 | Genetic anticipation (HP:0003743) | 1.73005593 |
| 157 | Striae distensae (HP:0001065) | 1.72773452 |
| 158 | Cerebral aneurysm (HP:0004944) | 1.72539004 |
| 159 | Tongue fasciculations (HP:0001308) | 1.71421514 |
| 160 | Aneurysm (HP:0002617) | 1.71245743 |
| 161 | Generalized tonic-clonic seizures (HP:0002069) | 1.71164566 |
| 162 | Camptodactyly of toe (HP:0001836) | 1.67644682 |
| 163 | Long toe (HP:0010511) | 1.67614436 |
| 164 | Cervical subluxation (HP:0003308) | 1.67480900 |
| 165 | Patent foramen ovale (HP:0001655) | 1.67137008 |
| 166 | Flat cornea (HP:0007720) | 1.66672082 |
| 167 | Focal motor seizures (HP:0011153) | 1.65169039 |
| 168 | Abnormality of the foot musculature (HP:0001436) | 1.62635735 |
| 169 | Abnormality of the nasal mucosa (HP:0000433) | 1.62582917 |
| 170 | Cholelithiasis (HP:0001081) | 1.62008585 |
| 171 | Limited hip movement (HP:0008800) | 1.61287022 |
| 172 | Hyperlipoproteinemia (HP:0010980) | 1.61075529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.70258020 |
| 2 | FRK | 4.48197843 |
| 3 | CASK | 3.36081806 |
| 4 | MYLK | 3.19725092 |
| 5 | TGFBR2 | 3.05067860 |
| 6 | OBSCN | 2.90841716 |
| 7 | KDR | 2.56438392 |
| 8 | DAPK2 | 2.52626324 |
| 9 | TTN | 2.44896534 |
| 10 | BMPR1B | 2.14576396 |
| 11 | MARK1 | 2.10127703 |
| 12 | PHKG1 | 2.02193053 |
| 13 | PHKG2 | 2.02193053 |
| 14 | PTK2B | 1.92928106 |
| 15 | PDGFRA | 1.84585008 |
| 16 | MAP3K4 | 1.74464342 |
| 17 | BCKDK | 1.68501467 |
| 18 | EPHB2 | 1.67287374 |
| 19 | MAP2K6 | 1.61523710 |
| 20 | EPHA4 | 1.54465465 |
| 21 | STK38L | 1.53047301 |
| 22 | PIK3CA | 1.50243131 |
| 23 | WNK3 | 1.49808178 |
| 24 | PDK4 | 1.49599763 |
| 25 | PDK3 | 1.49599763 |
| 26 | NTRK2 | 1.46673569 |
| 27 | LMTK2 | 1.45445085 |
| 28 | DMPK | 1.45240646 |
| 29 | ADRBK2 | 1.43220339 |
| 30 | TNK2 | 1.43201189 |
| 31 | PINK1 | 1.42427735 |
| 32 | WNK4 | 1.40214156 |
| 33 | INSRR | 1.39998426 |
| 34 | MAP4K2 | 1.37776751 |
| 35 | PRPF4B | 1.35687911 |
| 36 | RIPK1 | 1.34187827 |
| 37 | MAP2K4 | 1.29052907 |
| 38 | MAP2K7 | 1.28186648 |
| 39 | FER | 1.24424758 |
| 40 | MAPK12 | 1.16845118 |
| 41 | GRK7 | 1.14259227 |
| 42 | GRK1 | 1.12750256 |
| 43 | NTRK3 | 1.12553385 |
| 44 | MAPK13 | 1.11015795 |
| 45 | MAP3K12 | 1.09811240 |
| 46 | ACVR1B | 1.07889621 |
| 47 | MAPK15 | 1.07052503 |
| 48 | FGFR2 | 1.06715433 |
| 49 | DAPK3 | 1.04629511 |
| 50 | PRKCH | 1.04074151 |
| 51 | PDK2 | 1.04012187 |
| 52 | MUSK | 1.03316378 |
| 53 | SIK1 | 1.01158836 |
| 54 | UHMK1 | 0.98559541 |
| 55 | PLK2 | 0.97007923 |
| 56 | ROCK1 | 0.96910360 |
| 57 | FGFR4 | 0.95444134 |
| 58 | ERBB2 | 0.94881711 |
| 59 | TRIB3 | 0.93891737 |
| 60 | PRKD1 | 0.92632184 |
| 61 | PKN1 | 0.92153685 |
| 62 | PAK3 | 0.88565939 |
| 63 | STK11 | 0.88405476 |
| 64 | MAP3K6 | 0.87595579 |
| 65 | CAMK2A | 0.85986052 |
| 66 | PRKCE | 0.84444051 |
| 67 | TGFBR1 | 0.83235024 |
| 68 | TAOK3 | 0.81899281 |
| 69 | AKT3 | 0.81299850 |
| 70 | OXSR1 | 0.79604348 |
| 71 | STK24 | 0.77962006 |
| 72 | CSK | 0.77923664 |
| 73 | STK39 | 0.77393511 |
| 74 | MAPK7 | 0.76512020 |
| 75 | CAMK2D | 0.76306549 |
| 76 | MAP3K5 | 0.74986885 |
| 77 | MAP3K7 | 0.74669800 |
| 78 | FGFR3 | 0.74619968 |
| 79 | ZAK | 0.73025352 |
| 80 | GRK5 | 0.70011482 |
| 81 | CDK5 | 0.69207129 |
| 82 | NLK | 0.67355531 |
| 83 | MST1R | 0.65723407 |
| 84 | PDGFRB | 0.65457279 |
| 85 | CDC42BPA | 0.64729488 |
| 86 | ROCK2 | 0.63502447 |
| 87 | PRKG1 | 0.62447471 |
| 88 | PRKD3 | 0.62261602 |
| 89 | MARK2 | 0.61511562 |
| 90 | STK38 | 0.61383019 |
| 91 | LATS1 | 0.58967783 |
| 92 | DAPK1 | 0.58361115 |
| 93 | CAMKK1 | 0.56019444 |
| 94 | PKN2 | 0.55572183 |
| 95 | CAMK1 | 0.55351161 |
| 96 | NME1 | 0.55282469 |
| 97 | PRKCZ | 0.54582893 |
| 98 | PNCK | 0.54150811 |
| 99 | ITK | 0.53292204 |
| 100 | PDK1 | 0.53048671 |
| 101 | SGK2 | 0.52458315 |
| 102 | PRKD2 | 0.52386066 |
| 103 | CAMK1G | 0.51842226 |
| 104 | ADRBK1 | 0.51268125 |
| 105 | CAMK4 | 0.50655226 |
| 106 | SIK2 | 0.49612631 |
| 107 | PRKACB | 0.48259261 |
| 108 | TRPM7 | 0.47570071 |
| 109 | HIPK2 | 0.47436555 |
| 110 | PRKG2 | 0.47068163 |
| 111 | SGK223 | 0.46940887 |
| 112 | SGK494 | 0.46940887 |
| 113 | SGK3 | 0.46923598 |
| 114 | RPS6KA3 | 0.45787172 |
| 115 | ILK | 0.45533795 |
| 116 | PIK3CG | 0.45328318 |
| 117 | CAMK2B | 0.45132165 |
| 118 | PRKAA2 | 0.45060090 |
| 119 | PAK6 | 0.44931663 |
| 120 | PRKACA | 0.44858373 |
| 121 | EPHA3 | 0.43955009 |
| 122 | ERN1 | 0.43708097 |
| 123 | PRKCA | 0.43302805 |
| 124 | PRKCG | 0.43090351 |
| 125 | DYRK1A | 0.42943515 |
| 126 | MAP2K1 | 0.41270093 |
| 127 | LATS2 | 0.40995513 |
| 128 | CCNB1 | 0.40648720 |
| 129 | PDPK1 | 0.38419528 |
| 130 | JAK1 | 0.37704912 |
| 131 | CSNK1A1 | 0.35944497 |
| 132 | PRKAA1 | 0.35616885 |
| 133 | PRKACG | 0.34844890 |
| 134 | MINK1 | 0.34752649 |
| 135 | SRC | 0.34479521 |
| 136 | MET | 0.33420604 |
| 137 | CAMK2G | 0.33298156 |
| 138 | SGK1 | 0.31832024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.14978525 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.03859589 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.93998941 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.73779203 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.41662849 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.34797926 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26490322 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.20902021 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.06650860 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.04866778 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85086346 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.82492303 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82182488 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68811410 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.63572357 |
| 16 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.58045757 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.52516614 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50039926 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49005133 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.48601971 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47383025 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35458784 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34976176 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28881053 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27812928 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26559529 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22785006 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22737173 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20605408 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18184964 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15891900 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15233173 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12051205 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.10727016 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10152551 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.09225337 |
| 37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.06141737 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.05291021 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05071191 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.04841815 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.04164404 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 1.04137793 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04023413 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.03572969 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03323838 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01250338 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.01055493 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99775668 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99470150 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98764776 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98562889 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97642371 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96219682 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94997043 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94150503 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.93553212 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92865821 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92814024 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92564833 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91555005 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89140363 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87247531 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86414640 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.86259891 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85907864 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85812966 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.85673773 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85253011 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84557012 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83744219 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82313834 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81692972 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80807417 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80304231 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80063399 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77543738 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76269626 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.75021095 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73618675 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71984983 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71808603 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71795509 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.71126342 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67825253 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66278972 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66156122 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66026438 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65538786 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64383685 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64212025 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64029788 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.62604255 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62515917 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62384438 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61555832 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61158397 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60779116 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58611795 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58088739 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57571260 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.57197455 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.57158623 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.56845802 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.55729796 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.52534152 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52335603 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52300025 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51389816 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51297532 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51283688 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50784245 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50756058 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50006241 |
| 114 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49477973 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49438714 |
| 116 | Olfactory transduction_Homo sapiens_hsa04740 | 0.47958037 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46857480 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46777056 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.46650697 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45603463 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45529369 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44346625 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44328102 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44294647 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43525367 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40507351 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40453528 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.39616133 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39499608 |

